Compare BETA & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BETA | STVN |
|---|---|---|
| Founded | 2017 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | Aerospace | Containers/Packaging |
| Sector | Industrials | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.7B |
| IPO Year | 2025 | 2021 |
| Metric | BETA | STVN |
|---|---|---|
| Price | $22.71 | $21.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $35.25 | $25.67 |
| AVG Volume (30 Days) | ★ 2.6M | 291.6K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.39% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,616,000.00 | N/A |
| Revenue This Year | $14.75 | $9.67 |
| Revenue Next Year | $918.13 | $9.99 |
| P/E Ratio | ★ N/A | $27.15 |
| Revenue Growth | ★ 135.99 | N/A |
| 52 Week Low | $13.43 | $12.89 |
| 52 Week High | $36.43 | $27.99 |
| Indicator | BETA | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 53.00 | 47.47 |
| Support Level | $19.78 | $20.17 |
| Resistance Level | $31.16 | $22.00 |
| Average True Range (ATR) | 1.50 | 0.92 |
| MACD | 0.21 | -0.08 |
| Stochastic Oscillator | 61.77 | 32.72 |
BETA Technologies Inc is an aerospace company. The group has developed an electric aircraft platform and propulsion systems that are positioned to transform the aviation industry forward into a new phase of growth. It designs, manufactures, and sells high-performance electric aircraft, modern electric propulsion systems, charging systems, and components. The group also invested in the underlying infrastructure of this breakthrough technology, which is critical to bringing electric aviation to life. The group has developed a differentiated presence in North America and is well-positioned to expand globally. Its products and services are Aircraft, Charge, Motor, Battery, Flight Controls, and Training. It has one operating segment: Development and Manufacturing of Electric Aircraft.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.